Document:

exv10w28

Exhibit 10.28

September 17, 2007               

John Feeney

Dear John,

     Vanda Pharmaceuticals Inc. (the “Company”) is pleased to offer you employment on the following
terms:

     1. Position. Your title will be Senior Medical Officer and you will report to me. This is a
full-time position. By signing this letter agreement, you confirm to the Company that you have no
contractual commitments or other legal obligations that would prohibit you from performing your
duties for the Company. In your case, it is understood that your previous employer, the FDA places
certain restrictions on the activities of former employees and these restrictions will be honored
at Vanda.

     2. Base Salary. The Company will pay you a starting salary at the rate of $220,000 per year,
payable semi-monthly. This salary will be subject to adjustment pursuant to the Company’s employee
compensation policies in effect from time to time.

     3. Incentive Bonus. You will be eligible to be considered for an incentive bonus for each
fiscal year of the Company. The bonus (if any) will be awarded based on objective or subjective
criteria established by the Company’s Board of Directors. Your target bonus will be equal to 20%
of your annual base salary. Any bonus for the fiscal year in which your employment begins will be
prorated, based on the number of days you are employed by the Company during that fiscal year. The
bonus for a fiscal year will be paid after the Company’s books for that year have been closed and
will be paid only if you are employed by the Company at the time of payment. The determinations of
the Company’s Board of Directors with respect to your bonus will be final and binding.

     4. Employee Benefits. As a regular employee of the Company, you will be eligible to
participate in Company-sponsored benefits offered to other full-time employees. [These benefits
are described in the employee benefit summary that is enclosed with this letter agreement.] In
addition, you will be entitled to paid vacation in accordance with the Company’s vacation policy,
as in effect from time to time.

     5. Stock Options. Subject to the approval of the Company’s Board of Directors and its
Compensation Committee, you will be granted an option to purchase 20,000 shares of the Company’s
Common Stock. The exercise price per share will be equal to the fair market value per share on the
date the option is granted or on your first day of employment, whichever is later. The option will
be subject to the terms and conditions applicable to options granted under the Company’s Management
Equity Plan (the “Plan”), as described in the Plan and the applicable Management Equity Agreement.
You will vest in 25 % of the option shares after 12 months of continuous service, and the balance
will vest in equal monthly installments

Vanda Pharmaceuticals Inc. • 9605 Medical Center Drive • Suite 300 • Rockville, MD 20850 USA • p 240.599.4500 • f 301.294.1900

www.vandapharma.com

 

 

over the next 36 months of continuous service, as described in the applicable Management Equity
Agreement.

     6. Confidential Information Agreement. Like all Company employees, you will be required, as a
condition of your employment with the Company, to sign the Company’s Confidential Information
Agreement.

     7. Employment Relationship. Employment with the Company is for no specific period of time.
Your employment with the Company will be “at will,” meaning that either you or the Company may
terminate your employment at any time and for any reason, with or without cause. Any contrary
representations that may have been made to you are superseded by this offer. This is the full and
complete agreement between you and the Company on this term. Although your job duties, title,
compensation and benefits, as well as the Company’s personnel policies and procedures, may change
from time to time, the “at will” nature of your employment may only be changed in an express
written agreement signed by you and another executive officer of the Company, as approved by the
Company’s Board of Directors.

     8. Termination Benefits

(a) General Release. Any other provision of this offer notwithstanding, Subsections (b) and (c)
below shall not apply unless the Employee (i) has executed a general release (in a form prescribed
by the Company) of all known and unknown claims that he may then have against the Company or
persons affiliated with the Company and (ii) has agreed not to prosecute any legal action or other
proceeding based upon any of such claims.

(b) Severance Pay. If, during the term of this Agreement, the Company terminates the Employee’s
Employment for any reason other than Cause or Permanent Disability, or the Employee terminates his
Employment for Good Reason, then the Company shall pay the Employee:

(i) Base Compensation. His Base Compensation for a period of 4 months following the termination
of his Employment (the “Continuation Period”). Such Base Compensation shall be paid at the rate in
effect at the time of the termination of Employment and in accordance with the Company’s standard
payroll procedures.

(c) Health Insurance. If Subsection (b) above applies, and if the Employee elects to continue his
health insurance coverage under the Consolidated Omnibus Budget Reconciliation Act (“COBRA”)
following the termination of his Employment, then the Company shall pay the Employee’s monthly
premium under COBRA until the earliest of (i) the close of the Continuation Period, (ii) the
expiration of the Employee’s continuation coverage under COBRA and (iii) the date when the Employee
is offered substantially equivalent health insurance coverage in connection with new employment or
self-employment.

     9. Outside Activities. While you render services to the Company, you agree that you will not
engage in any other employment, consulting or other business activity without the prior written
consent of the Company. While you render services to the Company, you also will not assist any
person or entity in competing with the Company, in preparing to compete with the Company or in
hiring any employees or consultants of the Company.

 

 

     10. Withholding Taxes. All forms of compensation referred to in this letter agreement
are subject to reduction to reflect applicable withholding and payroll taxes and other deductions
required by law.

     11. Entire Agreement. This letter agreement supersedes and replaces any prior
agreements, representations or understandings, whether written, oral or implied, between you and
the Company.

     12. Arbitration. You and the Company agree to waive any rights to a trial before a judge
or jury and agree to arbitrate before a neutral arbitrator any and all claims or disputes arising
out of this letter agreement and any and all claims arising from or relating to your employment
with the Company, including (but not limited to) claims against any current or former employee,
director or agent of the Company, claims of wrongful termination, retaliation, discrimination,
harassment, breach of contract, breach of the covenant of good faith and fair dealing, defamation,
invasion of privacy, fraud, misrepresentation, constructive discharge or failure to provide a leave
of absence, or claims regarding commissions, stock options or bonuses, infliction of emotional
distress or unfair business practices.

     The arbitrator’s decision must be written and must include the findings of fact and law that
support the decision. The arbitrator’s decision will be final and binding on both parties, except
to the extent applicable law allows for judicial review of arbitration awards. The arbitrator may
award any remedies that would otherwise be available to the parties if they were to bring the
dispute in court. The arbitration will be conducted in accordance with the National Rules for the
Resolution of Employment Disputes of the American Arbitration Association; provided, however that
the arbitrator must allow the discovery that the arbitrator deems necessary for the parties to
vindicate their respective claims or defenses. The arbitration will take place in Maryland.

     You and the Company will share the costs of arbitration equally. Both the Company and you
will be responsible for your own attorneys’ fees, and the arbitrator may not award attorneys’ fees
unless a statute or contract at issue specifically authorizes such an award.

     This arbitration provision does not apply to (a) workers’ compensation or unemployment
insurance claims or (b) claims concerning the validity, infringement or enforceability of any trade
secret, patent right, copyright or any other trade secret or intellectual property held or sought
by either you or the Company (whether or not arising under the Proprietary Information and
Inventions Agreement between you and the Company).

     If an arbitrator or court of competent jurisdiction (the “Neutral”) determines that any
provision of this arbitration provision is illegal or unenforceable, then the Neutral shall modify
or replace the language of this arbitration provision with a valid and enforceable provision, but
only to the minimum extent necessary to render this arbitration provision legal and enforceable.

*      *      *

     We hope that you will accept our offer to join the Company. You may indicate your agreement
with these terms and accept this offer by signing and dating both the enclosed

 

 

duplicate original of this letter agreement and returning it to me. As required by law, your
employment with the Company is contingent upon your providing legal proof of your identity and
authorization to work in the United States.

     John, I look forward to your favorable response in writing within the next 10 days.

	 	 	 	 	 	 	 
	 	 	Very truly yours,	 	 
	 
	 	 	 	 	 	 
	 	 	Vanda Pharmaceuticals Inc.	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Paolo Baroldi, M.D.
 

	 	 
	 	 	Name: Paolo Baroldi, M.D.	 	 
	 	 	Title: Chief Medical Officer	 	 

I have read and accept this employment offer:

	 	 	 
	/s/ John Feeney
 

	 	 
	Signature of John Feeneyexv10w29

Exhibit 10.29

Vanda Pharmaceuticals Inc.

9605 Medical Center Drive, Suite 300

Rockville, MD 20850

December 17, 2008

Stephanie Irish

Dear Stephanie:

     Effective immediately, Vanda Pharmaceuticals Inc. (the “Company”) will provide you with the
following severance protection:

     1. General. If the Company terminates your employment for any reason other than Cause or
Permanent Disability and a Separation occurs, then you will be entitled to the benefits described
in this letter.1 However, this letter will not apply unless you (a) have returned all
Company property in your possession and (b) have executed a general release of all claims that you
may have against the Company or persons affiliated with the Company. The release must be in the
form prescribed by the Company, without alterations. The Company will deliver the form to you
within five business days after your Separation. You must execute and return the release within
the period set forth in the prescribed form.

     2. Salary Continuation. If the Company terminates your employment for any reason other than
Cause or Permanent Disability and a Separation occurs, then the Company will continue to pay your
base salary for a period of three months after your Separation. Your base salary will be paid at
the rate in effect at the time of your Separation and in accordance with the Company’s standard
payroll procedures. The salary continuation payments will commence not later than 30 days after
the last date for returning the release described in Section 1 above. The amount of the salary
continuation payments under this Section 2 will be reduced by the amount of any severance pay or
pay in lieu of notice that you receive from the Company under a federal or state statute
(including, without limitation, the WARN Act).

     3. COBRA. If the Company terminates your employment for any reason other than Cause or
Permanent Disability, a Separation occurs, and you elect to continue your health insurance coverage
under the Consolidated Omnibus Budget Reconciliation Act (“COBRA”) following your Separation, then
the Company will pay the same portion of your monthly premium under COBRA as it pays for active
employees until the earliest of (a) the close of the six-month period following your Separation,
(b) the expiration of your continuation coverage under COBRA or (c) the date when you become
eligible for substantially equivalent health insurance coverage in connection with new employment
or self-employment.

     4. Options. If the Company terminates your employment for any reason other than Cause or
Permanent Disability and a Separation occurs, then (a) the vested portion of the shares subject to
each of your options will be determined by adding three months to the actual

 

			
	1	 	Several capitalized terms are defined below.

 

 

Stephanie Irish

December 17, 2008

Page 2

period of service that you have completed with the Company and (b) each of your options will
be exercisable for six months (rather than three months) after your termination date.

     5. Tax Matters.

     (a) Withholding. All forms of compensation referred to in this letter are subject to
reduction to reflect applicable withholding and payroll taxes and other deductions required by law.

     (b) Section 409A. For purposes of Section 409A of the Internal Revenue Code of 1986, as
amended (the “Code”), each salary continuation payment under Section 2 is hereby designated as a
separate payment. If the Company determines that you are a “specified employee” under Section
409A(a)(2)(B)(i) of the Code at the time of your Separation, then (i) the salary continuation
payments under Section 2, to the extent that they are subject to Section 409A of the Code, will
commence during the seventh month after your Separation and (ii) the installments that otherwise
would have been paid during the first six months after your Separation will be paid in a lump sum
when the salary continuation payments commence.

     6. Definitions. The following terms have the meaning set forth below wherever they are used
in this letter:

     “Cause” means (a) your unauthorized use or disclosure of the Company’s confidential
information or trade secrets, which use or disclosure causes material harm to the Company, (b) your
material breach of any agreement between you and the Company, (c) your material failure to comply
with the Company’s written policies or rules, (d) your conviction of, or your plea of “guilty” or
“no contest” to, a felony under the laws of the United States or any State, (e) your gross
negligence or willful misconduct, (f) your continuing failure to perform assigned duties after
receiving written notification of the failure from the Company or (g) your failure to cooperate in
good faith with a governmental or internal investigation of the Company or its directors, officers
or employees, if the Company has requested your cooperation.

     “Permanent Disability” means that you are unable to perform the essential functions of your
position, with or without reasonable accommodation, for a period of at least 120 consecutive days
because of a physical or mental impairment.

     “Separation” means a “separation from service,” as defined in the regulations under Section
409A of the Code.

*   *   *   *   *

 

 

Stephanie Irish

December 17, 2008

Page 3

     If you have any questions, please call me at 240-599-4500.

	 	 	 	 	 	 	 
	 	 	Very truly yours,	 	 
	 
	 	 	 	 	 	 
	 	 	Vanda Pharmaceuticals Inc.	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Mihael H. Polymeropoulos
 

	 	 
	 	 	Title: Chief Executive Officer	 	 

I have read and accept this employment offer:

	 	 	 
	/s/ Stephanie Irish
 

	 	 
	Signature of Employee

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00155-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00155-of-00352.parquet"}]]